NCX-4016 has inhbitory effects on platelet cyclooxygenase and aggregability and is able to prevent monocyte activation ex vivo. NCX-4016 has a better gastric tolerability than aspirin
NO-Aspirin (NCX-4016) prevents platelet and monocyte activation inducing less gastric damage compared to aspirin
MINUZ, Pietro;MENEGUZZI, Alessandra;LECHI, Alessandro;
2004-01-01
Abstract
NCX-4016 has inhbitory effects on platelet cyclooxygenase and aggregability and is able to prevent monocyte activation ex vivo. NCX-4016 has a better gastric tolerability than aspirin
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
